TickerFactsScreenerDevelopers

Mineralys Therapeutics, Inc. (MLYS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: -$29.22M2023: -$81.17M2024: -$166.31M2025: -$142.42M-$142.42M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$142.42M+14.4%
2024-$166.31M-104.9%
2023-$81.17M-177.8%
2022-$29.22M—